HYBRID EVENT: Join us in person in Boston, Massachusetts, USA or attend virtually from anywhere.
13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Neurological Disorders and Stroke
Neurological Disorders and Stroke
Neurological Disorders:
Neurological disorders are medicinally described as disorders that affect the brain as well as the nerves found all over the human body and the spinal cord. Structural, biochemical or electrical deformity in the brain, spinal cord or other nerves can grow in to a range of symptoms. Examples of symptoms comprise disappearance of sense, muscle frailty, paralysis, seizures, substandard coordination, pain, confusion and altered levels of responsiveness.
- Acute Spinal Cord Injury
- Alzheimer's Disease
- Cerebral Aneurysm
- Epilepsy and Seizures
- Muscular Dystrophy
Stroke:
Stroke is the sudden death of brain cells due to lack of oxygen, caused by blockage of blood flow or burst of an artery to the brain. Sudden loss of speech, weakness, or paralysis of one side of the body can be symptoms.
- Ischemic Stroke
- Thrombotic Stroke
- Embolic Stroke
- Hemorrhagic Stroke
- Intracerebral Stroke
- Transient ischemic attack (TIA)
- Subarachnoid Stroke
Committee Members
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States INBC 2026 Speakers
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Andrzej Stanislaw Cieplak
Independent researcher, United States
Younok Dumortier Shin
OnusBio, United StatesSubmit your abstract Today
Title : Atypical presentation of Juvenile myoclonic epilepsy in a 16-year-old female: A case report
George Diaz, Memorial Healthcare Systems, United States
Title : Triple-network dysfunction, ME/CFS, and the NeuroPhysics Treatment Process “A dynamical systems perspective on psychophysical organization and environmental interaction”
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title : Beyond plaques: 10-nanometer-scale pathoconnectomics of Alzheimer’s disease
Ons M Saad, Panluminate Inc., United States
Title : Results from the global phase 3 trial (IB1001-303) evaluating levacetylleucine in children and adults with ataxia-telangiectasia
Chidinma Ejim, IntraBio, United States
Title : A phase 3, multinational, randomized, placebo-controlled, double-blind, crossover trial (IB1001-304) evaluating levacetylleucine in CACNA1A
Chidinma Ejim, IntraBio, United States
Title : Clinical and molecular phenotype of PTRHD1-associated juvenile parkinsonism
Bhavan A Modi, Barrow Neurological Institute at Phoenix Children's, United States